Webinar: The growing utilization of copay accumulator programs
New Copay Accumulator Policy Could Ignite Payer Trend on Medical Benefit Products
HTA and Affordability for Innovative Therapies in Germany, Perspectives on Advanced Therapy Medicinal Product (ATMP) Pathway
Skyrocketing Growth in PBM Formulary Exclusions Raises Concerns About Patient Access
Changes in Medicare Part D Benefit Design Can Impact Availability of Future Treatments
How Digital Innovation Drives Improved Market Access Strategies
In this digital age, how can pharmaceutical manufacturers leverage innovative tools to prove their product's value proposition and overcome market access challenges?
Copay Accumulators: Are Your Patients Really at Risk?
Two experts in health economics and patient support team up to offer insight on how manufacturers can prepare for the impact of copay accumulators.